Literature DB >> 10446805

Alzheimer disease: curly fibers and tangles in organs other than brain.

J Miklossy1, K Taddei, R Martins, G Escher, R Kraftsik, O Pillevuit, D Lepori, M Campiche.   

Abstract

The filamentous brain lesions that define Alzheimer disease (AD) consist of senile plaques and neurofibrillary tangles. Undulated pathological filaments--curly fibers or neuropil threads--also occur in the neuropil. Beta-amyloid precursor proteins are synthesized by many cells outside the central nervous system and recently, deposition of beta-amyloid-protein was reported to occur in non-neuronal tissues. In addition, increasing data claim the importance of chronic inflammation in the pathogenesis of AD. These observations suggest that AD may be a widespread systemic disorder. Here we report that pathological argyrophilic filaments with histochemical properties of amyloid showing striking morphological similarity to curly fibers and/or tangles accumulate not only in ependymal layer and in epithelial cells of choroid plexus, but also in several other organs (e.g. liver, pancreas, ovary, testis, thyroid) in AD. The ependyma, choroid plexus, and various organs of 39 autopsy cases were analyzed. In search of curly fiber and tangle-like changes in organs other than brain, 395 blocks from 21 different tissues of 24 AD cases, 5 cases with discrete or moderate AD-type changes, and 10 control cases were investigated. We found in non-neuronal cells "curly fibers" or "tangles" immunoreactive with antibodies to P component, Tau-protein, ubiquitin, fibronectin, and Apolipoprotein-E, but lacking immunoreactivity with antibodies to neurofilament proteins. Ultrastructurally they consist of densely packed straight and paired helical filaments and closely resemble neurofibrillary tangles and neuropil threads. These observations indicate that the formation of "curly fibers" and "tangles" is not unique to the central nervous system. The results suggest that AD might be a systemic disorder or that similar fibrillary changes to tangles and curly fibers may also be associated with other amyloidosis than beta-amyloidosis. Further investigations are necessary to understand the pathogenetic interest of these fibrillary changes outside the CNS.

Entities:  

Mesh:

Year:  1999        PMID: 10446805     DOI: 10.1097/00005072-199908000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  17 in total

Review 1.  Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.

Authors:  W Zheng
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

2.  Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models.

Authors:  Elena L Paley; Galina Denisova; Olga Sokolova; Natalia Posternak; Xukui Wang; Anna-Liisa Brownell
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 3.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

Review 4.  Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review.

Authors:  Francesco Raudino
Journal:  Neurol Sci       Date:  2013-03-31       Impact factor: 3.307

5.  Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.

Authors:  Mamta Behl; Yanshu Zhang; Yunzhou Shi; Jixin Cheng; Yansheng Du; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-05-19       Impact factor: 4.294

6.  The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.

Authors:  Brittany N Dugger; Charisse M Whiteside; Chera L Maarouf; Douglas G Walker; Thomas G Beach; Lucia I Sue; Angelica Garcia; Travis Dunckley; Bessie Meechoovet; Eric M Reiman; Alex E Roher
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

7.  Upregulation of zinc transporter 2 in the blood-CSF barrier following lead exposure.

Authors:  Xue Fu; Andrew Zeng; Wei Zheng; Yansheng Du
Journal:  Exp Biol Med (Maywood)       Date:  2013-12-05

8.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

Authors:  Judith Miklossy; Hong Qing; Aleksandra Radenovic; Andras Kis; Bertrand Vileno; Forró Làszló; Lisa Miller; Ralph N Martins; Gerard Waeber; Vincent Mooser; Fred Bosman; Kamel Khalili; Nune Darbinian; Patrick L McGeer
Journal:  Neurobiol Aging       Date:  2008-10-23       Impact factor: 4.673

9.  Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT.

Authors:  Huiying Gu; Paul R Territo; Scott A Persohn; Amanda A Bedwell; Kierra Eldridge; Rachael Speedy; Zhe Chen; Wei Zheng; Yansheng Du
Journal:  J Trace Elem Med Biol       Date:  2020-09-19       Impact factor: 3.849

10.  Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.

Authors:  Mamta Behl; Yanshu Zhang; Andrew D Monnot; Wendy Jiang; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-06       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.